{"transactions":[{"id":695917,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":26283,"kind":"person","name":"Carson Michael J.","position":1,"cik":"0001896079","reported_name":"Carson Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-08-05T21:26:08.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 shares of restricted common stock will fully vest on August 3, 2027, subject to Mr. Carson's continued service on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":230118,"source":{"system":"sec-edgar","filing":"0001104659-26-091279","document":"tm2622360-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896079/000110465926091279/tm2622360-1_4seq1.xml","form_type":"4"}},{"id":942312,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":26283,"kind":"person","name":"Carson Michael J.","position":1,"cik":"0001896079","reported_name":"Carson Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-09T21:30:17.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":61200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 61,200 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock."}],"balance_after":200118,"source":{"system":"sec-edgar","filing":"0001104659-26-002489","document":"tm262288-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896079/000110465926002489/tm262288-1_4seq1.xml","form_type":"4"}},{"id":1315387,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":26283,"kind":"person","name":"Carson Michael J.","position":1,"cik":"0001896079","reported_name":"Carson Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-01-03T23:10:32.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 51,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 138,918 shares of restricted common stock."}],"balance_after":138918,"source":{"system":"sec-edgar","filing":"0001104659-25-000910","document":"tm251747-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896079/000110465925000910/tm251747-2_4seq1.xml","form_type":"4"}},{"id":1371627,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":26283,"kind":"person","name":"Carson Michael J.","position":1,"cik":"0001896079","reported_name":"Carson Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-11-08T20:59:32.000Z","date":"2024-11-07","kind":"sale","planned":false,"acquired":false,"shares":2755,"price":8.159,"value":22478.045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the vesting of 9,100 shares, 2,755 shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Carson's tax withholding obligations. Mr. Carson had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":87918,"source":{"system":"sec-edgar","filing":"0001104659-24-115837","document":"tm2427970-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1896079/000110465924115837/tm2427970-1_4seq1.xml","form_type":"4"}},{"id":1371626,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":26283,"kind":"person","name":"Carson Michael J.","position":1,"cik":"0001896079","reported_name":"Carson Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-11-08T20:59:32.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":34567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The 34,567 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":90673,"source":{"system":"sec-edgar","filing":"0001104659-24-115837","document":"tm2427970-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1896079/000110465924115837/tm2427970-1_4seq1.xml","form_type":"4"}},{"id":1371625,"issuer":{"id":5166,"kind":"organization","name":"Nuvectis Pharma, Inc."},"owners":[{"id":26283,"kind":"person","name":"Carson Michael J.","position":1,"cik":"0001896079","reported_name":"Carson Michael J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2024-11-08T20:59:32.000Z","date":"2023-01-03","kind":"grant","planned":false,"acquired":true,"shares":28806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 28,806 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":56106,"source":{"system":"sec-edgar","filing":"0001104659-24-115837","document":"tm2427970-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896079/000110465924115837/tm2427970-1_4seq1.xml","form_type":"4"}}]}